Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 2/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.39 |
| ▸ | LATS1 | O95835 | 1/20 | 0.39 |
| ▸ | PLK4 | O00444 | 1/20 | 0.38 |
| ▸ | PAK4 | O96013 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.37 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
| ▸ | PGR | P06401 | 1/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.37 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.37 |
| ▸ | DRD1 | P21728 | 1/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4100811 | 0.89 | CYP2C19 (0.51) | CYP2C9CYP2C19PLK4PAK4CYP1A2 | |
| SCHEMBL10195902 | 0.84 | PTK2 (0.39) | CYP2C9CYP2C19LATS1CYP1A2CYP2D6 | |
| SCHEMBL4100661 | 0.81 | PLK4 (0.39) | PLK4PAK4DRD1BRAFSGK1 | |
| SCHEMBL13561246 | 0.80 | CYP2C9 (0.41) | CYP2C9CYP2C19LATS1CYP1A2CYP2D6 | |
| SCHEMBL11936689 | 0.78 | CYP2C9 (0.56) | HTR2CHTR2ACYP2C9CYP2C19PLK4 | |
| SCHEMBL11936660 | 0.77 | CYP2C9 (0.62) | HTR2CCYP2C9CYP2C19PLK4PAK4 | |
| SCHEMBL13561393 | 0.76 | CYP2C9 (0.38) | CYP2C9CYP2C19LATS1CYP1A2CYP2D6 | |
| SCHEMBL13561222 | 0.76 | CYP2C9 (0.37) | CYP2C9CYP2C19LATS1CYP1A2CYP2D6 | |
| SCHEMBL11947218 | 0.75 | CYP2C19 (0.51) | CYP2C9CYP2C19CYP1A2CYP2D6ABCC3 | |
| SCHEMBL11946965 | 0.75 | CYP2C19 (0.52) | CYP2C9CYP2C19CYP1A2CYP2D6ABCC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8372852-B2 | Purines as reverse transcriptase inhibitors | ARDEA BIOSCIENCES, INC. (US) | 2013-02-12 | — | — | US | disclosed |
| US-20120277206-A1 | REVERSE TRANSCRIPTASE INHIBITORS | Andrea Boesciences, Inc. (US) | 2012-11-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120277206-A1 | REVERSE TRANSCRIPTASE INHIBITORS | POLRMT, POLR1E, TYMP | HTR2C 4350/4885HTR2A 4004/4885CYP2C9 2156/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.